N-(4-Chlorobenzyl)-2-(((2-(2-chlorophenyl)-5-methyloxazol-4-yl)methyl)thio)acetamide

Catalog No. :
ACTVZM957
CAS No. :
902585-14-2
Molecular Formula :
C20H18Cl2N2O2S
Molecular Weight :
421.35

IUPAC Name:N-(4-chlorobenzyl)-2-(((2-(2-chlorophenyl)-5-methyloxazol-4-yl)methyl)thio)acetamide

N-(4-Chlorobenzyl)-2-(((2-(2-chlorophenyl)-5-methyloxazol-4-yl)methyl)thio)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(4-Chlorobenzyl)-2-(((2-(2-chlorophenyl)-5-methyloxazol-4-yl)methyl)thio)acetamide
IUPAC NameN-(4-chlorobenzyl)-2-(((2-(2-chlorophenyl)-5-methyloxazol-4-yl)methyl)thio)acetamide
Molecular FormulaC20H18Cl2N2O2S
Molecular Weight421.35
SMILESO=C(NCC1=CC=C(Cl)C=C1)CSCC2=C(C)OC(C3=CC=CC=C3Cl)=N2
InChI KeyWZZYSOTTXQWGBB-UHFFFAOYSA-N
SynonymAcetamide, N-[(4-chlorophenyl)methyl]-2-[[[2-(2-chlorophenyl)-5-methyl-4-oxazolyl]methyl]thio]-
CAS No.902585-14-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACTVZM957 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTVZM957 route product structure diagram
    ACTVZM957902585-14-2
Inquiry

2. ACTVZM957 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQDJE308 route compound structure diagram
    ACQDJE30842365-43-5 In Stock
  4. Then
  5. ACTVZM957 route product structure diagram
    ACTVZM957902585-14-2
Inquiry

Comments (0)